Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Goldenwell Biotech (GWLL) Interest Expenses (2020 - 2025)

Goldenwell Biotech's Interest Expenses history spans 4 years, with the latest figure at $2100.0 for Q3 2025.

  • For Q3 2025, Interest Expenses changed 0.0% year-over-year to $2100.0; the TTM value through Sep 2025 reached $10500.0, up 66.67%, while the annual FY2024 figure was $8400.0, 447.23% up from the prior year.
  • Interest Expenses reached $2100.0 in Q3 2025 per GWLL's latest filing, roughly flat from $2100.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $4200.0 in Q4 2024 to a low of -$1272.0 in Q4 2021.
  • Average Interest Expenses over 3 years is $1754.0, with a median of $2100.0 recorded in 2024.
  • The largest YoY upside for Interest Expenses was 5060.0% in 2021 against a maximum downside of 3161.54% in 2021.
  • A 3-year view of Interest Expenses shows it stood at -$1272.0 in 2021, then soared by 430.19% to $4200.0 in 2024, then crashed by 50.0% to $2100.0 in 2025.
  • Per Business Quant, the three most recent readings for GWLL's Interest Expenses are $2100.0 (Q3 2025), $2100.0 (Q2 2025), and $2100.0 (Q1 2025).